Literature DB >> 21778741

Reciprocal regulation of bone and energy metabolism.

Paul Baldock1.   

Abstract

BACKGROUND: The primary relationship affecting skeletal tissue involves the association between fat mass and bone mass. However, there is some complexity in this relationship that may be explained by endocrine and neural pathways representing direct, reciprocal signalling between fat and bone tissue. For example, leptin signalling can directly stimulate osteoblastic differentiation and osteoblast proliferation and mineralization, but it also has central signalling actions in that it decreases cancellous bone volume. A novel regulatory loop between bone and adipose tissue suggests that uncarboxylated osteocalcin may affect energy homeostasis and afford a pathway by which fat mass can be regulated by bone mass.
CONCLUSIONS: The multilayered and complex signals between fat and bone tissue involve both direct and indirect pathways. The endocrinologic nature of these signals highlights an emerging trend in medicine: identification of organ-based endocrine signals.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21778741     DOI: 10.1159/000329134

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  3 in total

1.  Adiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury.

Authors:  C O Tan; R A Battaglino; A L Doherty; R Gupta; A A Lazzari; E Garshick; R Zafonte; L R Morse
Journal:  Osteoporos Int       Date:  2014-07-01       Impact factor: 4.507

Review 2.  Hormonal protection in acute pancreatitis by ghrelin, leptin and melatonin.

Authors:  Jolanta Jaworek; Stanisław Jan Konturek
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

3.  Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults.

Authors:  Konstantinos N Aronis; Joo-Pin Foo; John P Chamberland; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2012-05-04       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.